| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cilium assembly | CEP120 DZIP1L KIAA0586 TBC1D2 CEP131 RP1 SPAG17 CFAP69 DNAH5 | 2.83e-06 | 444 | 56 | 9 | GO:0060271 |
| GeneOntologyBiologicalProcess | cilium organization | CEP120 DZIP1L KIAA0586 TBC1D2 CEP131 RP1 SPAG17 CFAP69 DNAH5 | 4.98e-06 | 476 | 56 | 9 | GO:0044782 |
| GeneOntologyBiologicalProcess | intramanchette transport | 7.24e-06 | 2 | 56 | 2 | GO:1990953 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.16e-05 | 109 | 56 | 5 | GO:0035082 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 4.59e-05 | 145 | 56 | 5 | GO:0001578 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CEP120 DZIP1L KIAA0586 TBC1D2 CEP131 RP1 SPAG17 CFAP69 DNAH5 | 7.38e-05 | 670 | 56 | 9 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | CEP120 DZIP1L KIAA0586 TBC1D2 CEP131 RP1 SPAG17 CFAP69 DNAH5 | 8.74e-05 | 685 | 56 | 9 | GO:0030031 |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 1.44e-05 | 18 | 56 | 3 | GO:0000159 | |
| GeneOntologyCellularComponent | axonemal central apparatus | 1.05e-04 | 6 | 56 | 2 | GO:1990716 | |
| GeneOntologyCellularComponent | axoneme | 2.30e-04 | 207 | 56 | 5 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.35e-04 | 208 | 56 | 5 | GO:0097014 | |
| GeneOntologyCellularComponent | protein serine/threonine phosphatase complex | 4.33e-04 | 55 | 56 | 3 | GO:0008287 | |
| GeneOntologyCellularComponent | phosphatase complex | 4.33e-04 | 55 | 56 | 3 | GO:1903293 | |
| GeneOntologyCellularComponent | centriole | 1.16e-03 | 172 | 56 | 4 | GO:0005814 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.58e-03 | 317 | 56 | 5 | GO:0032838 | |
| GeneOntologyCellularComponent | manchette | 2.55e-03 | 28 | 56 | 2 | GO:0002177 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.74e-03 | 360 | 56 | 5 | GO:0099568 | |
| GeneOntologyCellularComponent | M band | 3.12e-03 | 31 | 56 | 2 | GO:0031430 | |
| Domain | Tscrpt_reg_Wos2-domain | 8.21e-06 | 2 | 54 | 2 | IPR012642 | |
| Domain | LMSTEN | 8.21e-06 | 2 | 54 | 2 | PF07988 | |
| Domain | Cmyb_C | 2.46e-05 | 3 | 54 | 2 | PF09316 | |
| Domain | C-myb_C | 2.46e-05 | 3 | 54 | 2 | IPR015395 | |
| Domain | PP2A_PR55 | 4.90e-05 | 4 | 54 | 2 | IPR000009 | |
| Domain | PP2A_PR55_CS | 4.90e-05 | 4 | 54 | 2 | IPR018067 | |
| Domain | PR55_2 | 4.90e-05 | 4 | 54 | 2 | PS01025 | |
| Domain | PR55_1 | 4.90e-05 | 4 | 54 | 2 | PS01024 | |
| Domain | HTH_MYB | 2.92e-04 | 9 | 54 | 2 | PS51294 | |
| Domain | Myb_dom | 2.92e-04 | 9 | 54 | 2 | IPR017930 | |
| Domain | Myb_DNA-binding | 4.59e-03 | 35 | 54 | 2 | PF00249 | |
| Domain | MYB_LIKE | 5.40e-03 | 38 | 54 | 2 | PS50090 | |
| Domain | PRY | 6.56e-03 | 42 | 54 | 2 | PF13765 | |
| Domain | PRY | 8.50e-03 | 48 | 54 | 2 | SM00589 | |
| Domain | PRY | 8.50e-03 | 48 | 54 | 2 | IPR006574 | |
| Domain | TBC | 8.85e-03 | 49 | 54 | 2 | SM00164 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 1.99e-05 | 19 | 40 | 3 | M47525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 3.14e-05 | 22 | 40 | 3 | M47919 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.19e-04 | 34 | 40 | 3 | MM15985 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 1.94e-04 | 40 | 40 | 3 | M39595 | |
| Pubmed | Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. | 1.50e-06 | 14 | 57 | 3 | 9013886 | |
| Pubmed | 1.50e-06 | 14 | 57 | 3 | 9400615 | ||
| Pubmed | 1.50e-06 | 14 | 57 | 3 | 16048649 | ||
| Pubmed | Evolution of the regulators of G-protein signaling multigene family in mouse and human. | 1.53e-06 | 51 | 57 | 4 | 11829488 | |
| Pubmed | Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements. | 2.64e-06 | 2 | 57 | 2 | 38368814 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 31563982 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8570177 | ||
| Pubmed | Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases. | 2.64e-06 | 2 | 57 | 2 | 36074655 | |
| Pubmed | Arrest of spermatogenesis and defective breast development in mice lacking A-myb. | 2.64e-06 | 2 | 57 | 2 | 9109487 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 29410490 | ||
| Pubmed | A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. | 2.64e-06 | 2 | 57 | 2 | 31595312 | |
| Pubmed | DNA binding and transactivation activity of A-myb, a c-myb-related gene. | 2.64e-06 | 2 | 57 | 2 | 7987850 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 31028361 | ||
| Pubmed | 2.79e-06 | 17 | 57 | 3 | 17266553 | ||
| Pubmed | [Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors]. | 2.79e-06 | 17 | 57 | 3 | 21351466 | |
| Pubmed | 3.35e-06 | 18 | 57 | 3 | 23287597 | ||
| Pubmed | The myb gene family in cell growth, differentiation and apoptosis. | 7.91e-06 | 3 | 57 | 2 | 10378697 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 30988386 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 29149504 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 9514514 | ||
| Pubmed | Nucleolin, a novel partner for the Myb transcription factor family that regulates their activity. | 7.91e-06 | 3 | 57 | 2 | 10660576 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25251415 | ||
| Pubmed | 1.06e-05 | 26 | 57 | 3 | 11531413 | ||
| Pubmed | Subtraction cloning and initial characterization of novel epo-immediate response genes. | 1.58e-05 | 4 | 57 | 2 | 10880228 | |
| Pubmed | Temporal patterns of A-myb and B-myb gene expression during testis development. | 1.58e-05 | 4 | 57 | 2 | 8808690 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 23153538 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 23935956 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 15578586 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 35108544 | ||
| Pubmed | Binding specificity of protein phosphatase 2A core enzyme for regulatory B subunits and T antigens. | 3.94e-05 | 6 | 57 | 2 | 9847399 | |
| Pubmed | Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis. | 3.94e-05 | 6 | 57 | 2 | 23940504 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 16055500 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 20220139 | ||
| Pubmed | HSF1 transcriptional activity is modulated by IER5 and PP2A/B55. | 5.51e-05 | 7 | 57 | 2 | 25816751 | |
| Pubmed | 6.03e-05 | 46 | 57 | 3 | 18782753 | ||
| Pubmed | Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. | 7.34e-05 | 8 | 57 | 2 | 11007961 | |
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 17245430 | ||
| Pubmed | Analysis of the sperm flagellar axoneme using gene-modified mice. | 7.34e-05 | 8 | 57 | 2 | 32554934 | |
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 12370081 | ||
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 15638722 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 27146717 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 30595372 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 19762425 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.02e-04 | 1155 | 57 | 9 | 20360068 | |
| Pubmed | A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. | 1.18e-04 | 10 | 57 | 2 | 18548008 | |
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 15380617 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 18971272 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 21072166 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 27133822 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 15609325 | ||
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 2.36e-04 | 183 | 57 | 4 | 31932471 | |
| Pubmed | 2.37e-04 | 14 | 57 | 2 | 17531812 | ||
| Pubmed | Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling. | 2.37e-04 | 14 | 57 | 2 | 32123171 | |
| Pubmed | Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. | 2.73e-04 | 15 | 57 | 2 | 16041367 | |
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 15841179 | ||
| Pubmed | 3.90e-04 | 209 | 57 | 4 | 36779422 | ||
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 32582689 | ||
| Pubmed | C6orf118 VEZF1 SPTA1 DZIP1L PPIP5K2 SPAG17 CFAP69 RPL9 CCDC148 | 5.27e-04 | 1442 | 57 | 9 | 35575683 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 6.21e-04 | 101 | 57 | 3 | 24613305 | |
| Pubmed | 6.73e-04 | 650 | 57 | 6 | 38777146 | ||
| Pubmed | 7.00e-04 | 655 | 57 | 6 | 35819319 | ||
| Pubmed | 9.75e-04 | 118 | 57 | 3 | 30979931 | ||
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 9.75e-04 | 118 | 57 | 3 | 37105989 | |
| Pubmed | 1.18e-03 | 281 | 57 | 4 | 24163370 | ||
| Pubmed | 1.27e-03 | 32 | 57 | 2 | 17540176 | ||
| Pubmed | Multiple roles of FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout mouse models. | 1.27e-03 | 32 | 57 | 2 | 27739607 | |
| Pubmed | 1.43e-03 | 34 | 57 | 2 | 20301500 | ||
| Pubmed | Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. | 1.52e-03 | 35 | 57 | 2 | 19862010 | |
| Pubmed | 1.60e-03 | 36 | 57 | 2 | 22422068 | ||
| Cytoband | 5p15.2 | 5.21e-04 | 27 | 57 | 2 | 5p15.2 | |
| Cytoband | 2q32.1 | 6.44e-04 | 30 | 57 | 2 | 2q32.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p15 | 2.12e-03 | 204 | 57 | 3 | chr5p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q24 | 4.28e-03 | 78 | 57 | 2 | chr6q24 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.48e-06 | 15 | 33 | 3 | 696 | |
| GeneFamily | Zinc fingers CCCH-type | 1.85e-03 | 35 | 33 | 2 | 73 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | C6orf118 DZIP1L DPCD DHRS9 USP24 ECT2L SPAG17 CFAP69 DNAH5 CCDC148 | 5.09e-08 | 459 | 57 | 10 | M39136 |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | 5.58e-06 | 317 | 57 | 7 | M40298 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NBAS ASXL1 PPP2R2A SEMA3C PPP2R5A VEZF1 KLF6 USP24 PPIP5K2 MYBL1 | 1.41e-05 | 856 | 57 | 10 | M4500 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | SEMA3C C6orf118 DZIP1L DPCD ECT2L RP1 SPAG17 CFAP69 DNAH5 MYB CCDC148 | 2.00e-05 | 1093 | 57 | 11 | M41649 |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP | 4.65e-05 | 181 | 57 | 5 | M6857 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 7.46e-05 | 200 | 57 | 5 | M9327 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 7.46e-05 | 200 | 57 | 5 | M8765 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.61e-10 | 197 | 57 | 8 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-09 | 169 | 57 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.94e-09 | 185 | 57 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.09e-09 | 186 | 57 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.41e-09 | 188 | 57 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.57e-09 | 189 | 57 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.57e-09 | 189 | 57 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.92e-09 | 191 | 57 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.92e-09 | 191 | 57 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.92e-09 | 191 | 57 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 5.10e-09 | 192 | 57 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.48e-09 | 194 | 57 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.68e-09 | 195 | 57 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.68e-09 | 195 | 57 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.68e-09 | 195 | 57 | 7 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 5.88e-09 | 196 | 57 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.88e-09 | 196 | 57 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.88e-09 | 196 | 57 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-09 | 197 | 57 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.09e-09 | 197 | 57 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.09e-09 | 197 | 57 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.31e-09 | 198 | 57 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.76e-09 | 200 | 57 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 6.19e-08 | 162 | 57 | 6 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 7.41e-08 | 167 | 57 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 7.96e-08 | 169 | 57 | 6 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-07 | 178 | 57 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-07 | 179 | 57 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-07 | 180 | 57 | 6 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.23e-07 | 182 | 57 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-07 | 185 | 57 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-07 | 185 | 57 | 6 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.36e-07 | 185 | 57 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-07 | 187 | 57 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.49e-07 | 188 | 57 | 6 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-07 | 189 | 57 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.64e-07 | 191 | 57 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-07 | 191 | 57 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.64e-07 | 191 | 57 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-07 | 191 | 57 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.64e-07 | 191 | 57 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.69e-07 | 192 | 57 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-07 | 192 | 57 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.69e-07 | 192 | 57 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.69e-07 | 192 | 57 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.74e-07 | 193 | 57 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.74e-07 | 193 | 57 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.74e-07 | 193 | 57 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.74e-07 | 193 | 57 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-07 | 194 | 57 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.80e-07 | 194 | 57 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-07 | 195 | 57 | 6 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.85e-07 | 195 | 57 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-07 | 195 | 57 | 6 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-07 | 195 | 57 | 6 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.85e-07 | 195 | 57 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-07 | 195 | 57 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-07 | 196 | 57 | 6 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-07 | 196 | 57 | 6 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.91e-07 | 196 | 57 | 6 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.91e-07 | 196 | 57 | 6 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.91e-07 | 196 | 57 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-07 | 196 | 57 | 6 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.97e-07 | 197 | 57 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-07 | 197 | 57 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-07 | 197 | 57 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-07 | 197 | 57 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.97e-07 | 197 | 57 | 6 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 2.03e-07 | 198 | 57 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.09e-07 | 199 | 57 | 6 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.15e-07 | 200 | 57 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-06 | 154 | 57 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-06 | 154 | 57 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-06 | 155 | 57 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-06 | 155 | 57 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.76e-06 | 157 | 57 | 5 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.59e-06 | 170 | 57 | 5 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | ASK454-Epithelial-Ciliated|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.34e-06 | 179 | 57 | 5 | f21919ef9d3d984e2925ef3d24f89e20fe265dcd | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-06 | 181 | 57 | 5 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-06 | 181 | 57 | 5 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.52e-06 | 181 | 57 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.62e-06 | 182 | 57 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.62e-06 | 182 | 57 | 5 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-06 | 183 | 57 | 5 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-06 | 183 | 57 | 5 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.92e-06 | 185 | 57 | 5 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.92e-06 | 185 | 57 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 4.13e-06 | 187 | 57 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.24e-06 | 188 | 57 | 5 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.35e-06 | 189 | 57 | 5 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 4.35e-06 | 189 | 57 | 5 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.35e-06 | 189 | 57 | 5 | 38cde34295566a4ecaf7d0a81c5a192cf17d0459 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-06 | 189 | 57 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-06 | 189 | 57 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.35e-06 | 189 | 57 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.35e-06 | 189 | 57 | 5 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 4.46e-06 | 190 | 57 | 5 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 4.58e-06 | 191 | 57 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 4.58e-06 | 191 | 57 | 5 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.58e-06 | 191 | 57 | 5 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| Disease | Pathological accumulation of air in tissues | 1.41e-06 | 12 | 56 | 3 | C0013990 | |
| Disease | recalcitrant atopic dermatitis | 7.38e-05 | 7 | 56 | 2 | EFO_1000651 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 1.92e-04 | 11 | 56 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.31e-04 | 12 | 56 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Short Rib-Polydactyly Syndrome | 2.72e-04 | 13 | 56 | 2 | C0036996 | |
| Disease | Saldino-Noonan Syndrome | 3.17e-04 | 14 | 56 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 3.17e-04 | 14 | 56 | 2 | C0024507 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 5.93e-04 | 19 | 56 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Glioma | 6.13e-04 | 87 | 56 | 3 | C0017638 | |
| Disease | Joubert syndrome 1 | 7.26e-04 | 21 | 56 | 2 | C4551568 | |
| Disease | hemoglobin change measurement | 7.98e-04 | 22 | 56 | 2 | EFO_0600027 | |
| Disease | multiple myeloma | 1.27e-03 | 112 | 56 | 3 | EFO_0001378 | |
| Disease | red blood cell density measurement | 1.33e-03 | 880 | 56 | 7 | EFO_0007978 | |
| Disease | Polydactyly | 1.45e-03 | 117 | 56 | 3 | C0152427 | |
| Disease | erythrocyte measurement | 1.45e-03 | 257 | 56 | 4 | EFO_0005047 | |
| Disease | Familial aplasia of the vermis | 1.49e-03 | 30 | 56 | 2 | C0431399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NDKTIKLWKITERDK | 111 | Q9Y2T4 | |
| RRREKEEEKEKLWKK | 391 | Q8NFR7 | |
| DKTIKLWKISERDKR | 116 | P63151 | |
| KERLLEELKWKKATL | 286 | Q13410 | |
| LRKRIWEKIALRKKE | 186 | Q008S8 | |
| WEKIALRKKELFKVR | 191 | Q008S8 | |
| KKKKERTWAEAARLV | 6 | Q8IXJ9 | |
| TKLLRWVKKEEDRLF | 506 | Q7L1V2 | |
| AKLDISDELRKKIWT | 856 | Q08999 | |
| DSWQKRLDKETEKKR | 271 | Q9Y5P4 | |
| LREKTEIQKTEWKRK | 326 | Q8IYY4 | |
| KTKLERRKKASAWER | 276 | Q8WVP7 | |
| DLEKKRKLRKIEWMR | 171 | Q8NCR3 | |
| RRRLAEWKATKLKNK | 76 | Q9H2J4 | |
| KKIEELCREVKLWRK | 41 | Q6ZU52 | |
| TRWTREEDEKLKKLV | 41 | P10242 | |
| FIWKSIREKRLLDVK | 76 | Q9UKK3 | |
| WRLSTEKRKKIKDKE | 371 | A2RRP1 | |
| DKIKESLTLLRKKWA | 186 | Q96BN8 | |
| WKEEEKRKRKDIEKL | 236 | Q9BZI7 | |
| EWKKRDRERESLVKK | 686 | Q8N960 | |
| DEKTSELLVRKWRVK | 41 | Q9BVM2 | |
| SLQKKLETWEREKEK | 556 | Q9HC77 | |
| KVEKKRCEILSKWDE | 391 | Q5T5N4 | |
| VTIRKELKRKKKWDL | 311 | P12314 | |
| ELKRKKKWDLEISLD | 316 | P12314 | |
| RKALETDKKDWVKET | 396 | O60645 | |
| TAASLLIKLWRKEEK | 656 | A5D8W1 | |
| WTRKGKLKIEDITDK | 16 | Q9BPW9 | |
| KLLEREKDVRKWKEE | 571 | Q9BY12 | |
| RKTLKTLRDQWEKAL | 431 | O00411 | |
| RREKWISEKTKKIKE | 691 | Q9UPN4 | |
| KRDSKTNIWKKREER | 806 | Q6P995 | |
| VKWTRDEDDKLKKLV | 36 | P10243 | |
| WSSELLSKKKIQERK | 1051 | Q8TE73 | |
| TLRNKEVRETLLKKW | 291 | Q8NGZ6 | |
| KVRFRIKEEETIKWT | 336 | P56715 | |
| KLIKELTVTWEEKLR | 401 | Q9H1H9 | |
| EKMKRTLLKDWKTRL | 31 | P41220 | |
| IKWLLQKDKDRRKEV | 601 | Q99985 | |
| IAKILWRSAKKDVID | 896 | Q149N8 | |
| RWKEKIDKTRKEIET | 1881 | Q6Q759 | |
| REELWKKLEELKLKK | 451 | Q15172 | |
| TLRLWEEAVKARKKE | 366 | Q14119 | |
| SLLGKKKKRLRVDKW | 46 | P32969 | |
| RNKDKLTALERWKIK | 536 | Q5VZP5 | |
| ERDDLEKAWEKRKKI | 1376 | P02549 | |
| LEVEIAIKRADWKKT | 156 | P19474 | |
| EERKKSKELRSLWRK | 831 | O60343 | |
| ITKRTWRKEEKKLQE | 511 | A0A1B0GTU1 | |
| KKKLRVDTEEWIATI | 2181 | Q9UPU5 | |
| ASIEVLWKRDSLKVK | 61 | Q6ZQV5 | |
| LRRWSKLEKDFKTKN | 701 | O43314 | |
| LAWKKRKRQEKIDKL | 256 | Q8WU90 | |
| IVKKDTEDRITWKVK | 1451 | Q9BXT5 | |
| EKDKVWLLREQKRKK | 691 | Q8IWU5 | |
| SEKIRIRKTVDEWIK | 516 | Q9BVV6 | |
| IWRKVAEKEKALLTK | 481 | Q9BYX2 | |
| EDLWTKIILAREKKE | 61 | Q99612 | |
| DKLLRKADAKRRDWK | 1101 | Q5VTT5 | |
| ESLQKEWKETLKVLR | 86 | Q9HAN9 |